Dr. Suzanne Dahlberg: A Statistician’s Perspective on the Changing Landscape of Clinical Trials in Cancer Dr. West speaks with Dr. Suzanne Dahlberg about her path into biostatistics, leadership in shaping trials with ECOG & Dana Farber Cancer Institute, & changing endpoints & trial designs in an era of molecular oncology. (31:36) <span data-mce-type="bookmark" style="display: inline-block; width: 0px; overflow: hidden; line-height: 0;" class="mce_SELRES_start"></span> <span data-mce-type="bookmark" style="display: inline-block; width: 0px; overflow: hidden; line-height: 0;" class="mce_SELRES_start"></span>
